Back
Altimmune, Inc. 10K Form
Sell
48
ALT
Altimmune, Inc.
Last Price:
$5.32
Seasonality Move:
14.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ALT News And Ratings
See the #1 stock for the next 7 days that we like better than ALT
ALT Financial Statistics
Sales & Book Value
| Annual Sales: | $20K |
|---|---|
| Cash Flow: | $-11.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.94 |
| Price / Book: | 2.99 |
Profitability
| EPS (TTM): | -1.06880 |
|---|---|
| Net Income (TTM): | $-83.9M |
| Gross Margin: | $-218K |
| Return on Equity: | -56.24% |
| Return on Assets: | -49.18% |
Altimmune, Inc. Earnings Forecast
Key Altimmune, Inc. Financial Ratios
-
The Gross Profit Margin over the past 13 years for ALT is -1,090.00%.
-
The Selling, General & Administrative Expenses for ALT have been equal to 104,830.00% of Gross Profit Margin.
-
The Research & Development expenses have been 409,940.00% of Revenue.
-
The Net Earning history of ALT is -475,295.00% of Total Revenues.
-
Per Share Earnings over the last 20 years have been positive in 12 years.
Altimmune, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ALT |
| CUSIP: | 02155H |
| Website: | altimmune.com |
Debt
| Debt-to-Equity Ratio: | 0.09 |
|---|---|
| Current Ratio: | 17.18 |
| Quick Ratio: | 16.79 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ALT Technical Analysis vs Fundamental Analysis
Sell
48
Altimmune, Inc. (ALT)
is a Sell
Is Altimmune, Inc. a Buy or a Sell?
-
Altimmune, Inc. stock is rated a SellThe current Altimmune, Inc. [ALT] share price is $5.31. The Score for ALT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.